Home page - Cancerrxgene - Genomics of Drug Sensitivity in Cancer

Identifying molecular features of cancers that predict response to anti-cancer drugs.

Browse our data

Our website and results are part of an ongoing research project. These webpages are updated frequently and our results are not final or complete.

Search

What's new?

Release 7.0 (Mar 2018)

Secure login environment for collaborators, minor updates for drug response data and improved data downloads.

Curve fitting code is now available as an R package – gdscIC50 – available on GitHub.

Mailing List

To receive news and data release alert, please sign up Translation-announce

The Genomics of Drug Sensitivity in Cancer Project is a collaboration between the Cancer Genome Project at the Wellcome Sanger Institute (UK) and the Center for Molecular Therapeutics, Massachusetts General Hospital Cancer Center (USA). This work is funded by Wellcome.

Users have a non-exclusive, non-transferable right to use data files for internal, non-commercial research and educational purposes Please note: The data files are experimental and academic in nature and are not licensed or certified by any regulatory body. Genome Research Limited provides access to data files on an “as is” basis and excludes all warranties of any kind (express or implied).